Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis

The clinical heterogeneity regarding the response profile of the antitumor necrosis factor (anti-TNF) in patients with Crohn’s disease (CD) and psoriasis (PsO) is attributed, amongst others, to genetic factors that influence the regulatory mechanisms which orchestrate the inflammatory response. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Nani, Paraskevi, Ladopoulou, Melpomeni, Papaioannou, Evgenia H., Papagianni, Evangelia D., Antonatos, Charalabos, Xiropotamos, Panagiotis, Kapsoritakis, Andreas, Potamianos, Petros S., Karmiris, Konstantinos, Tzathas, Charalambos, Patsatsi, Aikaterini, Lazaridou, Elisavet, Zafiriou, Efterpi, Roussaki-Schulze, Angeliki, Georgiou, Sophia, Grafanaki, Katerina, Georgakilas, Georgios K., Vasilopoulos, Yiannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957441/
https://www.ncbi.nlm.nih.gov/pubmed/36833372
http://dx.doi.org/10.3390/genes14020445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957441/
https://www.ncbi.nlm.nih.gov/pubmed/36833372
http://dx.doi.org/10.3390/genes14020445

Ejemplares similares